Pharmacologic suppression of estrogens with aminoglutethimide as treatment of advanced breast carcinoma
- 1 December 1982
- journal article
- scandinavian breast-cancer-symposium
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 2 (4) , 375-383
- https://doi.org/10.1007/bf01805879
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.BMJ, 1981
- Aminoglutethimide: Review of Pharmacology and Clinical UsePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1981
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A reviewBreast Cancer Research and Treatment, 1981
- Cancer of the BreastNew England Journal of Medicine, 1980
- Serum Aminoglutethimide Levels: Studies of Serum Half‐Life, Clearance, and Patient ComplianceThe Journal of Clinical Pharmacology, 1979
- A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancerCancer, 1979
- Current status of estrogen and progesterone receptors in breast cancerCancer, 1977
- Biosynthesis of 17β-oestradiol in human breast carcinoma tissue and a novel method for its characterizationBritish Journal of Cancer, 1975
- Successful Medical Adrenalectomy With Amino-glutethimideJAMA, 1974